Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2025-12-24 @ 4:24 PM
NCT ID:
NCT07099066
Eligibility Criteria:
Inclusion Criteria:
* Subjects over 18 years old;
* Subjects who have given their consent and signed an informed, free and express consent form;
* Subjects with diagnosed ALS;
* Subjects affiliated to or benefiting from a social security scheme.
Exclusion Criteria:
* Subjects with contraindications to the collection of biological samples (blood, skin, urine).
* Subjects undergoing treatment likely to affect hemostasis (anticoagulants, platelet anti-aggregants, etc.) in the month prior to inclusion and during the study;
* Subjects with hereditary or acquired haemostasis disorders;
* Subjects who have undergone physical treatment (radiotherapy, etc.) on the area to be biopsied in the last 6 months;
* Lidocaine-intolerant subjects;
* Subjects who have reached the age of majority and are subject to a protective measure or are unable to express their consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07099066
Study Brief:
Protocol Section:
NCT07099066